The Textbook of Pharmaceutical Medicine
(Sprache: Englisch)
The Textbook of Pharmaceutical Medicine is the standard reference for everyone working and learning in pharmaceutical medicine. It is a comprehensive resource covering the processes and practices by which medicines are developed, tested and approved, and...
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
233.99 €
Produktdetails
Produktinformationen zu „The Textbook of Pharmaceutical Medicine “
Klappentext zu „The Textbook of Pharmaceutical Medicine “
The Textbook of Pharmaceutical Medicine is the standard reference for everyone working and learning in pharmaceutical medicine. It is a comprehensive resource covering the processes and practices by which medicines are developed, tested and approved, and the recognised text for the Diploma in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine.This fully revised Seventh Edition, which includes two new Editors, encompasses current developments within pharmaceutical medicine with new chapters on biological therapeutics, pharmacovigilance, vaccines, drugs for cancer, drug development in paediatrics and neonatalogy, the clinical trials directive, life cycle management of medicines, counterfeit medicines and medical marketing. Also included for easy reference, and referred to throughout the text, are the Declaration of Helsinki, Guidelines and Documentation for Implementation of Clinical Trials, relevant European Directives and the Syllabus for Pharmaceutical Medicine.
Written by an international team of leading academics, medical directors and lawyers, The Textbook of Pharmaceutical Medicine, Seventh Edition meets the needs of both those working in pharmaceutical medicine and preparing for the Diploma in Pharmaceutical Medicine.
The text breaks down into three core sections:
Part I: Research and Development
Part II: Regulation
Part III: Healthcare marketplace
View Table of Contents in detail
Inhaltsverzeichnis zu „The Textbook of Pharmaceutical Medicine “
ContributorsThe editors
Acknowledgements
List of abbreviations
Preface
Part I Research and development
1 Discovery of new medicines
Yves J. Ribeill
2 Pharmaceutical development
Michael Gamlen and Paul Cummings
3 Preclinical safety testing
Lutz Müller and Elisabeth Husar
4 Exploratory development
John Posner
5 Clinical pharmacokinetics
Paul Rolan and Valéria Molnár
6 Biological therapeutics
Peter Lloyd and Jennifer Sims
7 Objectives and design of clinical trials
John Posner and Steve Warrington
8 Conduct of clinical trials: Good Clinical Practice
Kate L.R. Darwin
9 Medical statistics
Andrew P. Grieve
10 Development of medicines: full development
Peter D. Stonier
11 Pharmacovigilance
Stephen F. Hobbiger, Bina Patel and Elizabeth Swain
12 Vaccines
John Beadle
13 Drugs for cancer
James Spicer and Johann De Bono
14 Ethics of human experimentation
Jane Barrett
15 Drug development in paediatrics and neonatology
Nazakat M. Merchant and Denis V. Azzopardi
16 Due diligence and the role of the pharmaceutical physician
Geoffrey R. Barker
Part II Regulation
17 A history of drug regulation in the UK
John P. Griffin
18 The Clinical Trials Directive
Fergus Sweeney and Agnès Saint Raymond
19 Human medicinal products in the European Union: Regulations, Directives and structures
Agnès Saint Raymond and Anthony J. Humphreys
20 Human medicinal products in the European Union: Procedures
Agnès Saint Raymond and Anthony J. Humphreys
21 European regulation of medical devices
Shuna Mason
22 Paediatric regulation
Heike Rabe and Agnès Saint-Raymond
23 Technical requirements for registration of pharmaceuticals for human use: The ICH process
Dean W.G. Harron
24 The regulation of drug products by the US Food
... mehr
and Drug Administration
Peter Barton Hutt
25 The US FDA in the drug development, evaluation and approval process
Richard N. Spivey, Judith K. Jones, William Wardell and William W. Vodra
26 Future prospects of the pharmaceutical industry and its regulation in the USA
Richard N. Spivey, William W. Vodra, Judith K. Jones and William Wardell
27 Regulatory and clinical trial systems in Japan
Mamiko Satake and Natsuko Hosoda
28 The regulation of therapeutic products in Australia
Elizabeth de Somer, Deborah Monk and Janice Hirshorn
Part III Health care marketplace
29 An Introduction to life cycle management of medicines
David Gillen
30 Availability of medicines online and counterfeit medicines
Ruth Diazaraque and David Gillen
31 The supply of unlicensed medicines for individual patient use
Ian Dodds-Smith and Ewan Townsend
32 Legal and ethical issues relating to medicinal products
Nick Beckett, Sarah Hanson and Shuna Mason
33 Medical marketing
David B. Galloway and Bensita M.V. Thottakam
34 Information and promotion
Charles De Wet
35 Economics of health care
Carole A. Bradley and Jane R. Griffin
36 Controls on NHS medicines prescribing and expenditure in the UK (a historical perspective) with some international comparisons
John P. Griffin and Geoffrey R. Barker
37 Pharmaceutical medicine in the emerging markets
Nadarajah Sreeharan, Jennie A. Sykes and Richard B. Nieman
38 Biosimilars
Raymond A. Huml and John Posner
Appendix 1 Declaration of Helsinki
Appendix 2 Agreements and Guidelines for Implementation of Clinical Trials
Appendix 3 D
Peter Barton Hutt
25 The US FDA in the drug development, evaluation and approval process
Richard N. Spivey, Judith K. Jones, William Wardell and William W. Vodra
26 Future prospects of the pharmaceutical industry and its regulation in the USA
Richard N. Spivey, William W. Vodra, Judith K. Jones and William Wardell
27 Regulatory and clinical trial systems in Japan
Mamiko Satake and Natsuko Hosoda
28 The regulation of therapeutic products in Australia
Elizabeth de Somer, Deborah Monk and Janice Hirshorn
Part III Health care marketplace
29 An Introduction to life cycle management of medicines
David Gillen
30 Availability of medicines online and counterfeit medicines
Ruth Diazaraque and David Gillen
31 The supply of unlicensed medicines for individual patient use
Ian Dodds-Smith and Ewan Townsend
32 Legal and ethical issues relating to medicinal products
Nick Beckett, Sarah Hanson and Shuna Mason
33 Medical marketing
David B. Galloway and Bensita M.V. Thottakam
34 Information and promotion
Charles De Wet
35 Economics of health care
Carole A. Bradley and Jane R. Griffin
36 Controls on NHS medicines prescribing and expenditure in the UK (a historical perspective) with some international comparisons
John P. Griffin and Geoffrey R. Barker
37 Pharmaceutical medicine in the emerging markets
Nadarajah Sreeharan, Jennie A. Sykes and Richard B. Nieman
38 Biosimilars
Raymond A. Huml and John Posner
Appendix 1 Declaration of Helsinki
Appendix 2 Agreements and Guidelines for Implementation of Clinical Trials
Appendix 3 D
... weniger
Bibliographische Angaben
- 2013, 7. Aufl., 854 Seiten, mit Abbildungen, Maße: 17,8 x 24,6 cm, Gebunden, Englisch
- Herausgegeben: John P. Griffin, John Posner, Geoffrey R. Barker
- Verlag: Wiley & Sons
- ISBN-10: 0470659874
- ISBN-13: 9780470659878
- Erscheinungsdatum: 28.05.2013
Sprache:
Englisch
Rezension zu „The Textbook of Pharmaceutical Medicine “
"This book is expected to be useful for pharmaceutical physicians and for anyone interested in learning about the various issues in drug discovery and development. In addition to many other topics, the regulatory aspects of drug development in the U.S., Europe, and Japan are well covered ... Nevertheless, this is an admirable effort and the book deserves a place on the bookshelves of pharmaceutical physicians. " ( Doody's , 30 August 2013)
Pressezitat
"This comprehensive volume covers the processes by which medicines are developed, tested and approved. The chapters are written by leading academics, medical directors and legal experts in the field of harmaceutical medicine and provide authorative and in-depth information for both physicians working in and those who are currently training in the pharmaceutical industry." (British Journal of Clinical Pharmacology, 22 April 2014)"This book is expected to be useful for pharmaceutical physicians and for anyone interested in learning about the various issues in drug discovery and development. In addition to many other topics, the regulatory aspects of drug development in the U.S., Europe, and Japan are well covered . . . Nevertheless, this is an admirable effort and the book deserves a place on the bookshelves of pharmaceutical physicians. " (Doody's, 30 August 2013)
Kommentar zu "The Textbook of Pharmaceutical Medicine"
0 Gebrauchte Artikel zu „The Textbook of Pharmaceutical Medicine“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "The Textbook of Pharmaceutical Medicine".
Kommentar verfassen